Citations

Citations to this article as recorded by  

• Association between femoral localized cortical thickening (“beaking” or “flaring”) and bisphosphonate duration in glucocorticoid-induced osteoporosis
  Yudai Yano, Sachiko Kawasaki, Takaaki Kosugi, Takahiro Mui, Hiroyuki Tamaki, Hikari Tasaki, Masatoshi Nishimoto, Kaori Tanabe, Masahiro Eriguchi, Ken-ichi Samejima, Yoshinobu Uchihara, Masakazu Okamoto, Yasuhiro Akai, Kazuhiko Tsuruya, Kenji Kawamura
  Journal of Bone and Mineral Metabolism.2026; 44(3): 354.     CrossRef
• Plant-derived extracellular vesicles as tools and targets for inflammatory diseases
  Fengyu Tan, Wangrui Liu, Tongfei Li, Liugen Li, Zhiqiang Chen, Abhimanyu Thakur, Kui Zhang, Cheng Zhan, Hailin Tang, Yuanliang Yan, Yong Li, Xudong Zhu, Zhijie Xu
  Journal of Nanobiotechnology.2026;[Epub]     CrossRef
• Sex differences in clinical and metabolic outcomes of glucocorticoid replacement therapy in adrenal insufficiency
  Kai Yu, Irina Bancos
  Pituitary.2026;[Epub]     CrossRef
• Underutilization of Osteoporosis Screening in Patients With Severe COPD and Long Term Corticosteroid Use
  Alistair Disraeli, Kenneth Nugent, Neha Mittal
  Journal of Primary Care & Community Health.2026;[Epub]     CrossRef
• Efgartigimod in myasthenia gravis: Efficacy and steroid-sparing benefits in a real-world cohort
  Xiao-Na Xu, Feng Jiang, Jin-Ming Li, Xiao Li, Rui Liu, Chang Liu, Tong-Yu Meng, Yue Zhang, Chun-Sheng Yang
  Clinical Neurology and Neurosurgery.2026; 268: 109465.     CrossRef
• Low-dose, not low-risk: potential adrenal suppression identified by a risk-based approach to ACTH testing
  Ryoko Asano, Satoshi Yamaguchi, Koichiro Shinoda, Hiroyuki Hounoki, Toshiki Kido, Masatoshi Kawataka, Naonori Sugishita, Miho Yamazaki, Ikuma Okada, Aoi Kobiyama, Masaru Kato
  Clinical Rheumatology.2026;[Epub]     CrossRef
• Primary hyperparathyroidism presenting as atraumatic bilateral hip fractures: a case report
  Kevin McCarroll, Aisling Carroll, Finlay Brennan, Daire Gargan, Donal Fitzpatrick, Rosaleen Lannon
  Journal of Medical Case Reports.2026;[Epub]     CrossRef
• Incidence, prevalence, and predictors of osteoporotic fracture in adult lung transplant recipients
  Elisabeth Ng, Shanal Kumar, Eldho Paul, Daniel Bennett, Luisa Rosi, Louise Fuller, Lauren Chiu, Shoshana Sztal-Mazer, Steven Ivulich, Greg Snell, Leon A. Bach, Kathryn L. Hackman
  JHLT Open.2025; 7: 100182.     CrossRef
• Progressive resisted exercise program combined with aerobic exercise on osteoporotic systemic lupus erythematous patients: a prospective randomized controlled trial
  Hadaya Mosaad Eladl, Nabil Mahmoud Abdel-Aal, Khadra Mohamed Ali, Doaa Ayoub Elimy, Nesma M. Allam
  Disability and Rehabilitation.2025; 47(15): 3887.     CrossRef
• Risk factors of osteoporotic vertebral fracture cascade and the relationship between blood glucose control and fracture occurrence
  Yuyu Fan, Junjie Qiao, Lixiang Ding, Hongxing Song, Yu Hou, Meng Yi, Xiutong Fang
  Journal of Back and Musculoskeletal Rehabilitation.2025; 38(2): 334.     CrossRef
• Evaluating the relationship between bone density, osteoporosis, and some risk factors
  Tran Thua Nguyen, Le Thi Ngoc Uyen, Phan Thị Minh Phương, Trần Thị Cẩm Tú, Nguyễn Thị Huệ
  Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế.2025; 17(2): 78.     CrossRef
• The link between osteoporosis and cardiovascular diseases: a review of shared mechanisms, risk factors, and therapeutic approaches
  Mohammad Hasan Sharafi, Afshin Nazari, Mostafa Cheraghi, Faraz Souri, Morteza Bakhshesh
  Osteoporosis International.2025; 36(7): 1129.     CrossRef
• Nuclear receptors as therapeutic targets in metabolic and cardiovascular disorders
  Feifei Li, Qiujing Chen, Yang Dai, Lin Lu
  iScience.2025; 28(12): 114042.     CrossRef
• Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide h
  Masayuki Iki, Kenji Fujimori, Shinichi Nakatoh, Junko Tamaki, Shigeyuki Ishii, Nobukazu Okimoto, Hironori Imano, Sumito Ogawa
  Osteoporosis International.2024; 35(5): 805.     CrossRef
• Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study
  So Young Park, Seong Hee Ahn, Gi Hwan Bae, Sunmee Jang, Mi Kyung Kwak, Ha Young Kim, Se Hwa Kim
  Osteoporosis International.2024; 35(10): 1779.     CrossRef
• Chronic airway disease as a major risk factor for fractures in osteopenic women: Nationwide cohort study
  Sung Hye Kong, Ae Jeong Jo, Chan Mi Park, Kyun Ik Park, Ji Eun Yun, Jung Hee Kim
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Bad to the bones: prescribing of drugs for the prevention and treatment of osteoporosis in patients on chronic glucocorticoids
  Sarah J. Billups, Vinh K Thai, Jacob Denkins, Ian C. Dettman, Micol S. Rothman
  Archives of Osteoporosis.2023;[Epub]     CrossRef
• High Risk of Fractures Within 7 Years of Diagnosis in Asian Patients With Inflammatory Bowel Diseases
  Hyung Jin Ahn, Ye-Jee Kim, Ho-Su Lee, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Beom-Jun Kim, Sang Hyoung Park
  Clinical Gastroenterology and Hepatology.2022; 20(5): e1022.     CrossRef
• Challenges in the diagnosis and management of glucocorticoid‐induced osteoporosis in younger and older adults
  Madhuni Herath, Bente Langdahl, Peter R. Ebeling, Frances Milat
  Clinical Endocrinology.2022; 96(4): 460.     CrossRef
• Comparative effectiveness of bisphosphonate treatments for the prevention of re-fracture in glucocorticoid-induced osteoporosis: protocol for a systematic review and meta-analysis
  Hongmin Chu, Bo-Hyoung Jang, GaYoon Kim, Seowoo Bae, Hyeju Lee, Seonghee Nam, Jeonghoon Ahn
  BMJ Open.2022; 12(9): e062537.     CrossRef
• Why Do We Need Proactive Management for Fracture Prevention in Long-Term Glucocorticoid Users?
  Han Seok Choi
  Endocrinology and Metabolism.2020; 35(3): 549.     CrossRef